We are proud to share that Glooko has been recognized by The Healthcare Technology Report as one of the Top 50 Healthcare Technology Companies of 2025. This honor reflects the progress we are making toward building a more connected, personalized, and accessible future for people with diabetes and the clinicians who support them.
Each year, this list highlights organizations that are shaping the trajectory of healthcare through innovation and meaningful impact. For Glooko, this recognition reinforces the work taking place across our teams to simplify the complexity of diabetes care. Whether it is bringing data from devices into a single platform, supporting timely clinical decision making, or expanding digital tools that help people manage their diabetes with confidence, our mission has remained constant. We aim to improve patient outcomes through connected care platforms that work in the real world.
This award also reflects how far we have come in strengthening our portfolio. From the continued evolution of the Glooko platform, to the future integration of the inpatient insulin dosing technology of EndoTool, developed by Monarch Medical Technologies, a Glooko Company, to our partnerships that expand clinical value and accessibility, we are building an innovative approach to diabetes management that spans the full care journey. These advancements are the direct result of our teams’ expertise and commitment to the people who rely on our products every day.
Most importantly, this recognition is a reminder of why we do this work. Behind every data point is a person managing a lifelong condition while balancing the demands of life, family, and care. Our responsibility is to meet them where they are with tools that are intuitive, reliable, and informed by real clinical needs.
We are honored to be included among so many forward-thinking healthcare technology leaders. As we look to 2026, we remain focused on delivering solutions that empower clinicians, support health systems, and make life better for people with diabetes around the world.
EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions.